(2021). Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway [Retraction]. Am J Transl Res.
Chicago Style aipamena"Sequential Treatment of Phenethyl Isothiocyanate Increases Sensitivity of Temozolomide Resistant Glioblastoma Cells By Decreasing Expression of MGMT Via NF-κB Pathway [Retraction]." Am J Transl Res 2021.
MLA aipamena"Sequential Treatment of Phenethyl Isothiocyanate Increases Sensitivity of Temozolomide Resistant Glioblastoma Cells By Decreasing Expression of MGMT Via NF-κB Pathway [Retraction]." Am J Transl Res 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.